GURUFOCUS.COM » STOCK LIST » Technology » Software » Genpact Ltd (NYSE:G) » Definitions » Sloan Ratio %

Genpact (Genpact) Sloan Ratio % : 4.57% (As of Dec. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Genpact Sloan Ratio %?

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

Genpact's Sloan Ratio for the quarter that ended in Dec. 2023 was 4.57%.

As of Dec. 2023, Genpact has a Sloan Ratio of 4.57%, indicating the company is in the safe zone and there is no funny business with accruals.


Genpact Sloan Ratio % Historical Data

The historical data trend for Genpact's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genpact Sloan Ratio % Chart

Genpact Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sloan Ratio %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.26 -0.20 -4.06 -1.17 4.57

Genpact Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Sloan Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.17 -2.40 -2.94 -0.86 4.57

Competitive Comparison of Genpact's Sloan Ratio %

For the Information Technology Services subindustry, Genpact's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genpact's Sloan Ratio % Distribution in the Software Industry

For the Software industry and Technology sector, Genpact's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where Genpact's Sloan Ratio % falls into.



Genpact Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

Genpact's Sloan Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Sloan Ratio=(Net Income (A: Dec. 2023 )-Cash Flow from Operations (A: Dec. 2023 )
-Cash Flow from Investing (A: Dec. 2023 ))/Total Assets (A: Dec. 2023 )
=(631.255-490.812
--78.944)/4805.713
=4.57%

Genpact's Sloan Ratio for the quarter that ended in Dec. 2023 is calculated as

Sloan Ratio=(Net Income (TTM)-Cash Flow from Operations (TTM))
-Cash Flow from Investing (TTM))/Total Assets (Q: Dec. 2023 )
=(631.255-490.812
--78.944)/4805.713
=4.57%

Genpact's Net Income for the trailing twelve months (TTM) ended in Dec. 2023 was 106.101 (Mar. 2023 ) + 116.252 (Jun. 2023 ) + 117.593 (Sep. 2023 ) + 291.309 (Dec. 2023 ) = $631 Mil.
Genpact's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2023 was -34.064 (Mar. 2023 ) + 171.446 (Jun. 2023 ) + 161.524 (Sep. 2023 ) + 191.906 (Dec. 2023 ) = $491 Mil.
Genpact's Cash Flow from Investing for the trailing twelve months (TTM) ended in Dec. 2023 was -33.589 (Mar. 2023 ) + -12.324 (Jun. 2023 ) + -14.157 (Sep. 2023 ) + -18.874 (Dec. 2023 ) = $-79 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Genpact  (NYSE:G) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

As of Dec. 2023, Genpact has a Sloan Ratio of 4.57%, indicating the company is in the safe zone and there is no funny business with accruals.


Genpact Sloan Ratio % Related Terms

Thank you for viewing the detailed overview of Genpact's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


Genpact (Genpact) Business Description

Traded in Other Exchanges
Address
22 Victoria Street, Canon's Court, Hamilton, BMU, HM 12
Genpact Ltd is a provider of business process management services. Clients are industry verticals and operate in banking and financial services, insurance, capital markets, consumer product goods, life sciences, infrastructure, manufacturing and services, healthcare, and high-tech. Genpact's services include aftermarket, direct procurement, risk and compliance, human resources, IT, industrial solutions, collections, finance and accounting, and media services. Genpact's end market by revenue is India. The company is a General Electric spin-off, which is still a large source of revenue for Genpact.
Executives
Kathryn Vanpelt Stein officer: Senior Vice President 40 WEST 24TH STREET, APT 3N, NEW YORK NY 10010
N. V. Tyagarajan officer: Executive Vice President 825 EIGHTH AVENUE, NEW YORK NY 10019
Michael Hal Weiner officer: Chief Financial Officer C/O NGHC, 59 MAIDEN LANE, 38TH FLOOR, NEW YORK NY 10038
Donald J Klunk officer: Chief Accounting Officer 3585 GRAY FOX DR, CHALFONT PA 18914
Piyush Mehta officer: Senior VP , Human Resources 825 EIGHTH AVENUE, NEW YORK NY 10019
James C. Madden director 825 EIGHTH AVENUE, NEW YORK NY 10019
Cecelia Morken director 26025 MUREAU ROAD, CALABASAS CA 91302
Heather White officer: SVP & General Counsel 1155 AVENUE OF THE AMERICAS, 4TH FLOOR, NEW YORK X1 10036
Stacey Cartwright director 34 ROEDEAN CRESCENT, LONDON X0 SW15 5JU
Brian Mark Stevens director 25 HOOPER HILL RD., NEW BOSTON NH 03070
Ajay Agrawal director 105 ROBERT STREET, TORONTO A6 M5S 2K5
Tamara Franklin director 107 STONE CLIFF ROAD, PRINCETON NJ 08540
Balkrishan Kalra officer: Senior Vice President 5 MARION AVENUE, SHORT HILLS NJ 07078
Carol Lindstrom director 5994 SILVERADO TRAIL, NAPA CA 94558
Darren Saumur officer: Senior Vice President 125 DUPONT STREET, TORONTO A6 M5R 1V4